Rare cancer research firm RareCan seals six-figure investment to drive business growth

28 Jun

Written By Alexandra Collingbourne

Alexandra Collingbourne

Tripism CEO Kerr Assesses Travel Management Evolution

Perks, cash and an eye on the US for digital health doyen Boutros Bear